Topic
Insulin Access
17 published works
Hall Benefits Law Blog
Oregon Sues Drug Companies and PBMs Over High Insulin Prices
By Anne Hall
The state of Oregon has filed a $900 million lawsuit against American insulin manufacturers and pharmacy benefit managers (PBMs). According to the lawsuit, drug manufacturers and PBMs colluded in violation…
Hall Benefits Law Blog
Indiana Sues Eli Lilly Over Skyrocketing Insulin Prices
By Anne Hall
The state of Indiana has filed suit against Indiana-based drug manufacturer Eli Lilly and Co. for conspiring with other manufacturers and pharmacy benefit managers (PBMs) to artificially inflate insulin prices…
Drug & Device Law
First Circuit Approves Federal Officer Jurisdiction In Insulin Pricing Row
Federal officer jurisdiction is the quiet middle child of the federal jurisdiction family. We all came out of law school fully versed in federal question jurisdiction and diversity jurisdiction (and…
Health Law Prof Blog
A Competition Law Approach to Accessing Insulin
Frederick M. Abbott (Florida State University), Padmashree Gehl Sampath (Harvard University), A Competition Law Approach to Accessing Insulin (Working Paper, United Nations Dev. Programme (2022):The World Health Organization (WHO) estimates…
State AG Blog
State AG Updates: November 16-29, 2023
By Toni Michelle Jackson, Anna Kufta
Each week, Crowell & Moring’s State Attorneys General team highlights significant actions that State AGs have taken. Here are this week’s updates. Multistate The New York Attorney General Letitia James…
Napoli Shkolnik Blog
Lawsuit Filed Insulin Pricing Scheme Complaint on Behalf of Cattaraugus County, NY Against 19 Major Players in Pharma Industry
Complaint Claims Opaque, Conspiratorial Kickback Scheme Exponentially Increased Defendants’ Profits at the Expense of Plaintiff, its Plan Members and Other Payers Napoli Shkolnik has filed a lawsuit on behalf of…
Big Molecule Watch
Insulin Updates: March 2023
On March 1, Eli Lilly was the first to announce U.S. list price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program…
Nonprofit Law Blog
Nonprofit Tweets of the Week – 3/3/23
Stay informed of the week’s notable events and shared resources with this curated list of Nonprofit Tweets of the Week. Notable Events of the Week: “Alone and Exploited, Migrant Children…
Ogletree Deakins Insights
New HDHP Insulin Safe Harbor Under Inflation Reduction Act of 2022
On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (IRA) (P.L. 117-169), a budget reconciliation act focused on tax reform, climate change, and healthcare…
Take Stock: Federal Policy Watch
Washington Healthcare Update | Mar. 21, 2022
By Stephanie A. Kennan, Gina Sherick, McGuireWoods LLP
This Week in Washington: President Biden Signs Omnibus Appropriations Package into Law to Fund the Federal Government Through FY 2022 Congress House Reps. Maloney, Pressley and Bush Call for Expansion…